Erratum: Guest Editorial: Platelets and Cancer (Seminars in Oncology (2014) 41:3 (300-301) DOI: 10.1053/j.seminoncol.2014.04.011);Guest editorial: Platelets and cancer

Seminars in Oncology

Volumn 41, Issue 3, 2014, Pages 300-301

  Carr, Brian I ^a  

^a NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; INTERLEUKIN 6; PLATELET DERIVED GROWTH FACTOR; SEROTONIN; SOMATOMEDIN C; THROMBOPOIETIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANGIOGENESIS; ANTICOAGULANT THERAPY; CANCER CHEMOTHERAPY; CANCER PREVENTION; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER THERAPY; EDITORIAL; HUMAN; IMMUNE RESPONSE; METASTASIS; NEOPLASM; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTOSIS; TUMOR GROWTH; TUMOR MICROENVIRONMENT; VENOUS THROMBOEMBOLISM;

ANTINEOPLASTIC AGENTS; BLOOD PLATELETS; HUMANS; NEOPLASMS;

EID: 84904188503     PISSN: 00937754     EISSN: 15328708     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2014.08.008     Document Type: Erratum

References (34)

1. A. Trousseau Phlegmasia alba dolens Clin Med Hotel Dieu Paris 3 1865 654 712
2. E.A. Edwards Migrating thrombophlebitis associated with carcinoma N Engl J Med 240 1949 1031 1035
3. H.T. Sørensen, L. Mellemkjaer, F.H. Steffensen, J.H. Olsen, and G.L. Nielsen The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism N Engl J Med 338 17 1998 1169 1173
4. I. Riess Zur pathologischen anatomie des blutes Arch Anat Physiol Wissensch Med 39 1872 (237-49)
5. J. Levin, and C.L. Conley Thrombocytosis associated with malignant disease Arch Intern Med 114 1964 497 500
6. M.J. Proctor, D.S. Morrison, and D. Talwar et al. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study Eur J Cancer 47 2011 2633 2641
7. S. Krenn-Pilko, U. Langsenlehner, and E.-M. Thurner et al. The elevated pre-operative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients Br J Cancer March 2014 27 (Epub ahead of print)
8. H.C. Kwon, S.H. Kim, and S.Y. Oh et al. Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer Biomarkers 17 2012 216 222
9. Q. Lai, E. Castro Santa, and J.M. Rico Juri et al. Neutrophil and platelet-to-lymphocyte ratio as new predictors of dropout and recurrence after liver transplantation for hepatocellular carcinoma Transplant Int 27 2014 32 41
10. M. Leslie Cell biology: beyond clotting: the powers of platelets Science 328 2010 562 564
11. D. Buergy, F. Wenz, C. Groden, and M.A. Brockmann Tumor-platelet interaction in solid tumors Int J Cancer 130 2012 2747 2760
12. H.A. Goubran, T. Burnouf, M. Radosevic, and M. El-Ekiaby The platelet-cancer loop Eur J Intern Med 24 2013 393 400
13. N.M. Bambace, and C.E. Holmes The platelet contribution to cancer progression J Thromb Hemostat 9 2011 237 249
14. M. Labelle, S. Begum, and R.O. Hynes Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis Cancer Cell 20 2011 576 590
15. D. Sharma, K.E. Brummel-Ziedins, B.A. Bouchard, and C.E. Holme Platelets in tumor progression: a host factor that offers multiple potential targets in the treatment of cancer J Cell Physiol 229 8 2014 1005 1015
16. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill Cancer-related inflammation Nature 454 2008 436 444
17. J.D. Yang, I. Nakamura, and L.R. Roberts The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets Semin Cancer Biol 21 2011 35 43
18. R.L. Stone, A.M. Nick, and I.A. McNeish et al. Paraneoplastic thrombocytosis in ovarian cancer N Engl J Med 366 2012 610 618
19. I.A. Voutsadakis Thrombocytosis as a prognostic marker in gastrointestinal cancers World J Gastrointest Oncol 6 2014 36 40
20. S.J. Hwang, J.C. Luo, and C.P. Li et al. Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma World J Gastroenterol 10 2004 2472 2477
21. B.I. Carr, and V. Guerra Thrombocytosis and hepatocellular carcinoma Dig Dis Sci 58 2013 1790 1796
22. B. Psaila, D. Lyden, and Roberts I. Megakaryocytes malignancy and bone marrow vascular niches J Thromb Haemost 10 2012 177 178
23. G. Sitia, R. Aiolfi, and P. Di Lucia et al. Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B Proc Natl Acad Sci U S A 109 32 2012 E2165 E2172
24. B.I. Carr, A. Cavallini, and R. D'Alessandro et al. Platelet extracts induce growth, migration and invasion in human hepatocellular carcinoma in vitro BMC Cancer 14 2014 43
25. L. Borsig The role of platelet activation in tumor metastasis Expert Rev Anticancer Ther 8 2008 1247 1255
26. O. Dashevsky, D. Varon, and A. Brill Platelet-derived microparticles promote invasiveness of prostate cancer cells via upregulation of MMP-2 production Int J Cancer 124 2009 1173 1177
27. R. Li, M. Ren, and N. Chen et al. Presence of intratumoral platelets is associated with tumor vessel structure and metastasis BMC Cancer 14 2014 167
28. S. Karpatkin, E. Pearlstein, C. Ambrogio, and B.S. Coller Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo J Clin Invest 81 1988 1012 1019
29. G.J. Gasic, T.B. Gasic, and C.C. Stewart Antimetastatic effects associated with platelet reduction Proc Natl Acad Sci U S A 61 1968 46 52
30. J.P. Stone, and D.D. Wagner P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer J Clin Invest 92 1993 804 813
31. M. Demers, B. Ho-Tin-Noé, D. Schatzberg, J.J. Yang, and D.D. Wagner Increased efficacy of breast cancer chemotherapy in thrombocytopenic mice Cancer Res 71 2011 1540 1549
32. A. Radziwon-Balicka, C. Medina, and L. O'Driscoll et al. Platelets increase survival of adenocarcinoma cells challenged with anticancer drugs: mechanisms and implications for chemoresistance Br J Pharmacol 167 2012 787 804
33. P.M. Rothwell, J.F. Price, and F.G. Fowkes et al. Short-term effects of daily aspirin on cancer incidence, mortality and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials Lancet 379 2012 1602 1612
34. E. Bastiaannet, K. Sampieri, and O.M. Dekkers et al. Use of aspirin postdiagnosis improves survival for colon cancer patients Br J Cancer 106 2012 1564 1570